INTERNATIONAL PATENT: DANA-FARBER CANCER INSTITUTE, INC., ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC., H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. FILES APPLICATION FOR "CHEMICAL MATTERS FOR TARGETING HISTONE ACETYLTRANSFERASE P300 (EP300) AND CREB-BINDING PROTEIN (CBP)"

GENEVA, July 3 -- DANA-FARBER CANCER INSTITUTE, INC. (450 Brookline AvenueBoston, Massachusetts 02215), ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. (262 Danny Thomas PlaceMemphis, Tennessee 38105), H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (12902 Magnolia DriveTampa, Florida 33612-9416) filed a patent application (PCT/US2024/060546) for "CHEMICAL MATTERS FOR TARGETING HISTONE ACETYLTRANSFERASE P300 (EP300) AND CREB-BINDING PROTEIN (CBP)" on Dec 17, 2024. With publication no. WO/2025/136961, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Or...